News Roswell Park Earns ‘Exceptional’ Rating from National Cancer Institute With Best-Ever Core Grant
News Younger Patients Included in Clinical Trials Targeting Severe Aplastic Anemia: Immune suppressive therapy vs. matched unrelated donor BMT for severe aplastic anemia
News Younger Patients Included in Clinical Trials Targeting Sarcoma: A novel immunotherapy approach for sarcoma
News Pediatric Multicenter Study Shows Targeted Therapy for High-Risk Hodgkin Lymphoma Reduces Relapse
News From ASCO 2022: Brentuximab Vedotin and Chemotherapy an Effective Treatment for Hodgkin Lymphoma
News Can Ethnicity Hold Clues to Painful Side Effects in Young Leukemia Patients? Roswell Park Wins Grant to Find Out
Video Checkmate 744: Subgroup Analyses of an International Trial for Relapsed Pediatric Hodgkin Lymphoma